The hepatic Ashwell-Morell receptor (AMR) can bind and remove desialylated platelets. Here we demonstrate that platelets become desialylated as they circulate and age in blood. Binding of desialylated platelets to the AMR induces hepatic expression of thrombopoietin (TPO) mRNA and protein, thereby regulating platelet production. Endocytic AMR controls TPO expression through Janus kinase 2 (JAK2) and the acute phase response signal transducer and activator of transcription 3 (STAT3) in vivo and in vitro. Recognition of this newly identified physiological feedback mechanism illuminates the pathophysiology of platelet diseases, such as essential thrombocythemia and immune thrombocytopenia, and contributes to an understanding of the mechanisms of thrombocytopenia observed with JAK1/2 inhibition.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303234PMC
http://dx.doi.org/10.1038/nm.3770DOI Listing

Publication Analysis

Top Keywords

ashwell-morell receptor
8
desialylated platelets
8
receptor regulates
4
regulates hepatic
4
hepatic thrombopoietin
4
thrombopoietin production
4
production jak2-stat3
4
jak2-stat3 signaling
4
signaling hepatic
4
hepatic ashwell-morell
4

Similar Publications

Notch signaling regulates cell-fate decisions in several developmental processes and cell functions. However, the role of Notch in hepatic thrombopoietin (TPO) production remains unclear. We noted thrombocytopenia in mice with hepatic Notch1 deficiency and so investigated TPO production and other features of platelets in these mice.

View Article and Find Full Text PDF

Platelets are small, versatile blood cells that are critical for hemostasis/thrombosis. Local platelet accumulation is a known contributor to proinflammation in various disease states. However, the anti-inflammatory/immunosuppressive potential of platelets has been poorly explored.

View Article and Find Full Text PDF

Sepsis, characterized by an uncontrolled host inflammatory response to infections, remains a leading cause of death in critically ill patients worldwide. Sepsis-associated thrombocytopenia (SAT), a common disease in patients with sepsis, is an indicator of disease severity. Therefore, alleviating SAT is an important aspect of sepsis treatment; however, platelet transfusion is the only available treatment strategy for SAT.

View Article and Find Full Text PDF
Article Synopsis
  • The session discussed new insights into the hemostatic system, particularly focusing on advances in coagulation and platelet biology, comparing traditional cascade models with newer cell-based and vascular models.
  • It highlighted the aging process of platelets and their recognition by the Ashwell-Morell receptor, leading to increased production of thrombopoietin in the liver.
  • The impact of certain therapeutic agents on thrombocytopenia was addressed, including Mylotarg's effect on megakaryocyte development and an acetyl co-A carboxylase inhibitor's role in disrupting platelet production, along with developments in gene therapy for hemophilia B and tools for predicting prothrombotic states.
View Article and Find Full Text PDF

Thrombopoietin accumulation in hepatocytes induces a decrease in its serum levels in a sinusoidal obstruction syndrome model.

Mol Med Rep

June 2022

Department of Hepato‑Biliary‑Pancreatic Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa 920‑8641, Japan.

Sinusoidal obstruction syndrome (SOS) is a type of fatal hepatic injury, which predominantly occurs following exposure to drugs, such as oxaliplatin, or bone marrow transplantation. Extravasated platelet aggregation (EPA) plays an important role in the development of SOS in rat and mouse models. Furthermore, platelets invading the space of Disse adhere to hepatocytes and are phagocytized in patients with SOS.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!